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Abstract 
Nucleic acids are of key biological importance due to their range of functions and ability to form 
various different structures, with an example of emerging significance being quadruplexes formed by 
guanine-rich sequences. These guanine rich sequences are found in different regions of the genome 
such as telomeres, gene promoters and introns and UTRs of mRNAs. Here a new approach has been 
developed that utilises surface enhanced Raman scattering (SERS) for the detection of the formation 
of G-quadruplexes. Three G-quadruplex stabilising ligands that each have their own unique SERS 
response were used in this study and their ability to act as reporters assessed. A SERS response was 
only obtained from the ligands in the absence of G-quadruplex formation. This resulted in an 
 “ŽŶ ?ŽĨĨ ?method which was successfully used to qualitatively detect the formation of G-quadruplex 
using quadruplex-forming sequences such as human telomeric and C-MYC promoter DNAs. The 
unique SERS spectra of each stabilising ligand offer the potential for use of SERS to study higher 
order DNA structures. This work shows that the ligands used can act simultaneously as a potential 
therapeutic stabilising agent and a SERS reporter, therefore allowing the use of SERS as a method of 
analysis of the formation of G-quadruplex DNAs. 
 
Introduction 
G-quadruplexes are guanine rich sequences that are capable of forming stable structures under 
physiological conditions in vivo.
1, 2
 They are composed of G-quartets that are a result of Hoogsteen 
hydrogen-bonding between guanines, which stack on top of each other producing four-stranded 
helical structures ŚĞůĚƚŽŐĞƚŚĞƌďǇʋ-ʋŝŶƚĞƌĂĐƚŝŽŶƐ.3, 4 The structure and stability of G-quadruplexes 
have been investigated using methods such as gel electrophoresis, circular dichroism and UV melting 
analysis.
5
 The structure and stability of G-quadruplexes are known to be dependent on various 
factors including the nature of the sequence, flanking nucleotides, loop length and concentration as 
well as the presence of monovalent cations such as K
+
 and Na
+
.
6, 7
 
8
 The specific cation can have an 
overall effect on the topology of the G-quadruplex. For example, in the presence of Na
+
, human 
telomeric DNA sequence, AG3(T2AG3)3, folds into anti-parallel structures, whereas in the presence of 
K
+
, TTAGGG repeats can fold into at least five distinct quadruplex structures.
9, 10
  
Numerous biochemical and structural studies have shown that guanine rich DNA sequences can 
spontaneously fold into G-quadruplex DNA structures in vitro and more recent studies have shown 
that quadruplexes have certain functions in vivo.
2
 G-quadruplexes are involved in regulating 
telomere maintenance, as well as transcription, replication and translation.
3
 Telomeres are 
nucleoprotein complexes and their main function is to protect the end of eukaryotic chromosomes 
containing repetitive guanine-rich DNA.
1
 Telomeres can be structurally complex, in somatic cells 
telomeres are shortened by 50-200 bases after each successive cycle of cell division. This is due to 
the inability of DNA polymerase to replicate the telomeric DNA strand due to the unavailability of 
 ? ?K,ŐƌŽƵƉĂƚƚŚĞĞǆƚƌĞŵĞĞŶĚŽĨƚŚĞĐŚƌŽŵŽsome (end replication problem). When telomeres are 
shortened critically, they reach the hayflick limit and cells become senescent and induce apoptotic 
signals. Nevertheless, telomere length is maintained in  ࡱ85% cancers, by the enzyme, telomerase, 
which is notably absent in somatic cells. The formation of a G-quadruplex structure is an ideal 
approach to the inhibition of telomerase activity because it is capable of isolating the substrate of 
telomerase, a single stranded telomeric DNA sequence.
11
 
Recently, there has been extensive research on the development of G-quadruplex ligands, 
particularly ones that target the human telomeric repeat [d(T2AG3)4] and would consequently block 
the action of telomerase.
12-14
 G-quadruplexĞƐ ŚĂǀĞ Ă ůĂƌŐĞƌ ʋ-surface area compared to DNA as a 
result of the four coplanar bases compared to two in duplexes. The majority of small molecules that 
ďŝŶĚƚŽƚŚĞƐĞƐƚƌƵĐƚƵƌĞƐĂůƐŽŚĂǀĞůĂƌŐĞʋ-ƐƵƌĨĂĐĞƐŝŶŽƌĚĞƌƚŽŵĂǆŝŵŝƐĞƚŚĞʋ-ʋŝŶƚĞƌĂĐƚŝŽŶƐƚŚĂƚǁŝůů 
form.
15
 Small organic molecules can lead to cell death by displacing the protective telomeric 
components or sequestering the substrate needed for telomeric activity.
16, 17
 Telomestatin is a 
natural product that was isolated from the bacterium Streptomyces anulatus and has been shown to 
be a very potent telomerase inhibitor.
18
 
There are several spectroscopic techniques that can be used to investigate the structure and stability 
of G-quadruplexes, such as UV molecular absorption
19
, circular dichroism (CD)
20
, fluorescence 
(FRET)
21
 and NMR
22
. UV/CD techniques have the most sensitive instrumental response to the 
interaction between the G-quadruplex strands, additionally CD can be used to determine if the 
quadruplex has parallel or anti-parallel configuration.
23
 Raman spectroscopy is an alternative 
technique which can be used to analyse the structure of macromolecules such as DNA. It was 
successfully applied to the investigation of the phosphodiester backbone conformation and the 
hydrogen-bonding interactions of quadruplexes.
24
 Miura et al identified specific Raman markers as 
indicators of the presence of parallel or anti-parallel G-quadruplexes.
25
 Raman spectroscopy is 
limited by the relatively low cross section of the Raman scattering process compared to other 
techniques such as fluorescence and absorption spectroscopy. Surface enhanced Raman scattering 
(SERS) has now become an appealing alternative technique as it overcomes the limitations 
associated with Raman spectroscopy.
26
 The high sensitivity achieved when using SERS is due to the 
enhancement of the Raman cross section when the analyte is in close proximity to a metal surface, 
which is usually in the form of a thin metallic film or a colloidal suspension. There have been several 
studies involving the direct detection of DNA bases or short DNA sequences utilizing SERS. Kneipp et 
al applied SERS to the detection of adenine bases, and emphasising the capability of SERS to be used 
as a method for single molecule detection.
27
 Bell at al successfully used SERS for the label free 
detection of DNA bases further emphasising the capability of SERS to be used for DNA detection.
28
 
The detection of DNA structures has proved to be more difficult due to the enhancement of Raman 
scattering having a high dependence on the orientation of the DNA with respect to the metallic 
surface. However, Breuzard et al demonstrated that it is possible to use SERS to analyse DNA 
structures by using the technique to investigate the stability of G-quadruplexes.
29
 Results revealed 
that there was a decrease in ethidium bromide SERS signal when it was bound to a quadruplex 
structure. Rusciano et al then further developed the application of SERS as a method to determine 
the stability of G-quadruplexes by using direct SERS analysis to gain information on the structure of 
guanine-rich DNA sequences.
30
 Different G-quadruplex structures were analysed and their relative 
stabilities were compared. Specific Raman features of G-quadruplex DNAs were identified in the 
SERS spectra and subsequent analysis on the phosphate backbone conformation and the strength of 
the Hoogsteen-like hydrogen bonding was performed.
30
 This demonstrated for the first time that 
SERS can be an extremely useful technique for the analysis of the stabilities of different G-
quadruplex structures.  
 
G-quadruplexes can be used as potential therapeutic targets for anti-cancer therapy.
31
 The ligand 
2,6-diamidoanthraquinone was shown to stabilise a quadruplex structure and inhibit telomerase 
activity.
32
 Since then, many classes of ligands have been reported as G-quadruplex stabilising agents, 
however very few of these have shown specificity towards the targeted quadruplex structure over 
other DNA topologies. Some ligands have also been shown to be indirect inhibitors of telomerase by 
displacing the telomere binding proteins that then induce a DNA damage response.
33, 34
 Therefore, 
there has been great interest in developing strong and selective quadruplex binding agents that can 
detect the presence of quadruplex structures in vivo.
17
 
 Here, we report the use of SERS for the qualitative detection of the formation of G-quadruplex 
structures. SERS is used as a method to monitor the formation of G-quadruplexes that is based on 
the unique SERS response given by three G-quadruplex stabilising ligands. When the ligand is added 
to a solution containing duplex DNA, it remains unbound and free, upon addition of silver 
nanoparticles aggregation occurs resulting in a strong SERS response. However, when the ligand is 
added to a solution of G-quadruplex DNAs, the ligand binds strongly to this DNA structure therefore 
when silver nanoparticles are added; the ligand is no longer free to induce aggregation or a SERS 
response (Figure 1). The ligands used here are 360A previously reported by Granotier et al,
35
 and the 
other two ligands, 3AQN and 6AQN, are reported by us and were shown previously to stabilise 
various quadruplexes (telomeric, C-KIT1, C-KIT2 and C-MYC) selectively over duplex DNA (Figure 2).
36
 
For the first time we report the use of SERS as the analysis method due to the ability of the ligands 
to act as Raman reporters. Various guanine-rich DNA sequences were used in this study, including 
the human telomeric sequence and the sequence from promoter of C-MYC gene. We have 
demonstrated the first report of these stabilising ligands being used to analyse the formation of G-
quadruplex DNAs over duplex DNA by SERS, which has previously been done using fluorescence 
based methods. 
 
 
Figure 1 Schematic overview of the qualitative detection of G-quadruplex DNA. (a) When the stabilising ligand is added 
to a solution containing G-quadruplex DNAs, the ligand strongly binds to the G-quadruplex and when silver 
nanoparticles are added, the ligand is not free to induce aggregation and a unique SERS response. (b) When the 
stabilising ligand is added to a solution conatining duplex DNAs, the ligand does not bind to this DNA structure, 
therefore in the presence of silver nanoparticles, aggreagtion occurs resulting in a SERS response from the ligand.  
 
 Figure 2 Structures of the three selective G-quadruplex binding ligands. From left: 3AQN (3-amino-quinolinium 
naphthyridine); 6AQN (6-amino-quinolinium naphthyridine) and 360A (3-amino-quinolinium pyridine). 
 
Materials and Methods 
Ligand Synthesis 
The three ligands (3AQN, 6AQN and 360A) used in this study were synthesized as reported 
previously.
36
 
Colloid Synthesis 
Silver nanoparticles were synthesised using a modified Lee and Meisel method.
37
 Silver nitrate 
(90 mg) was dissolved in distilled water (500 mL). The solution was heated rapidly to boiling with 
continuous stirring. Once boiling, an aqueous solution of sodium citrate (1 %, 10 mL) was added 
quickly. The heat was reduced and the solution was left to boil gently for 90 min with stirring. The 
colloid was then analysed by UV-ǀŝƐƐƉĞĐƚƌŽƐĐŽƉǇĂŶĚƚŚĞʄmax was 403 nm with the full width half-
height (FWHH) measured to be 124 nm. The concentration of the colloid was calculated to be 
0.2 nM.  
Oligonucleotides 
All DNAs were purchased on a 0.2 µmole scale with HPLC purification from Eurofins MWG 
(Ebersberg, Germany).  
Name Description ^ĞƋƵĞŶĐĞ ? ? ? ?  ? ? ? 
Peroxidase Deoxyribozyme  Quadruplex GTGGGTAGGGCGGGTTGG 
Human Telomeric DNA Quadruplex AGGGTTAGGGTTAGGGTTAGGG 
C-MYC Promoter Quadruplex TGAGGGTGGGTAGGGTGGGTAA 
Control Duplex   
(Self complementary) 
CAATCGGATCGAATTCGATCCGATTG 
Table 1 Oligonucleotides used in this study. 
 
SERS Analysis 
SERS analysis was performed using an Avalon Plate Reader (Belfast, UK), with an excitation 
wavelength of 532 Ŷŵ ? ? ?ǁĞůůƉůĂƚĞǁĂƐƉůĂĐĞĚŽŶƚŽĂƐƚĂŐĞĂŶĚƚŚĞŝŶƐƚƌƵŵĞŶƚ ?ƐƐŽĨƚǁĂƌĞǁĂƐ
used to automatically move the stage so that spectra could be recorded from each well. The 
accumulation time was 10 s. A single well can hold 300 µL. Prior to SERS analysis, the ligand (5 x 10
-
5
 M, 20 µL) and the specific DNA (5 x 10
-5
 M, 20 µL) were premixed at room temperature for 30 
minutes. This mixture was then added to the well that contained citrate reduced silver nanoparticles 
(0.2 nM, 260 µL). In the studies involving the presence or absence of monovalent cations, either NaCl 
(100 mM, 20 µL) or KCl (100 mM, 20 µL) was used. The samples were then analysed immediately. 
For peak intensity studies, three replicate samples were scanned 5 times each, with the peak 
intensities then being averaged to calculate the differences. Spectra were baseline corrected using a 
multipoint polynomial fit and level and zero mode using Grams software (AI 7.00). 
 
Results and Discussion 
Bisquinolinium ligands such as 360A are known to selectively bind and stabilise quadruplex nucleic 
acids over duplex DNA.
38-40
 Recently we reported two new derivatives of bisquinolinium 
carboxamide having 1,8-naphthyridine as the central core
36
 (Figure 2). Various biophysical and 
biochemical studies were used to investigate the interaction between the ligands and different 
nucleic acids. Circular dichroism (CD) melting assays indicated that ligands can impart higher 
stabilisation to quadruplex DNA over duplex DNA. Furthermore, CD studies were used to investigate 
the potential of these ligands to induce quadruplex formation in different DNA sequences. As 
observed with telomestatin, in the absence of monovalent cations, the ligands induced the 
formation of a quadruplex structure. A Fluorescent Intercalator Displacement (FID) assay 
demonstrated the ligands (3AQN, 6AQN and 360A) have high binding affinity and selectivity for 
quadruplex DNA over duplex DNA. Here, we report the use of surface enhanced Raman scattering 
(SERS) for the direct detection of the interaction of these ligands with G-quadruplex DNA that does 
not require the additional use of any other fluorescent agent. This is possible as the ligands 
themselves give a unique SERS response therefore the interaction between the ligand and DNA can 
be directly measured. This has potential future implications for the detection of the formation of G-
quadruplexes in vivo for use in diagnostic applications.  
 
Initial experiments were performed to determine if the three ligands gave a SERS response by 
addition of the ligands directly to a suspension of silver nanoparticles. As can be seen in Figure 3, 
each ligand had a unique SERS response due to their structural variations. A SERS response was 
obtained due to the ability of the ligands at the concentration used (50 µM) to aggregate the 
nanoparticles causing the SERS enhancement.  
 
Figure 3 SERS spectra obtained for each stabilising ligand using citrate reduced silver nanoparticles. (a) SERS spectrum of 
3AQN, (b) SERS spectrum of 6AQN and (c) SERS spectrum of 360A. Spectra were obtained using 532 nm laser excitation 
and an accumulation time of 1 second. 
 
With the knowledge that each of the ligands gave a unique SERS response, they were then incubated 
for 30 minutes at room temperature with the peroxidase deoxyribozyme quadruplex sequence 
(Table 1), to study the SERS signal when the ligand was bound to G-quadruplex DNAs. As can be seen 
in Figure 4, there is a significant reduction in SERS signal when each of the three ligands is bound to 
the G-quadruplex sequence. This indicates that the ligand was now complexed into the G-
quadruplex DNAs, which prevented the ligands from interacting with the surface of the silver 
nanoparticles, resulting in the reduced SERS intensity observed. 
 Figure 4 SERS spectra of free ligand (red) and peroxidase deoxyribozyme complex (black): (a) spectra of 3AQN free and 
complexed to G-quadruplex DNA, (b) spectra of 6AQN free and complexed to G-quadruplex sequence and (c) spectra of 
360A free and complexed to G-quadruplex sequence. Spectra were obtained using 532 nm laser excitation and an 
accumulation time of 1 second. 
 
To demonstrate the specificity of the binding ligands towards G-quadruplexes, the SERS signal was 
obtained from the interaction of the ligands with a duplex DNA compared to a G-quadruplex 
structure (Table1), the results are shown in Figure 5. For each ligand, SERS signals were obtained 
when the duplex control sequence was used in place of the G-quadruplex sequence. This suggests 
that the ligands do not bind strongly to the duplex allowing them to remain free in solution and to 
come into close proximity to the surface of the silver nanoparticles resulting in a SERS signal. 
However, when a G-quadruplex is present a much reduced SERS signal is observed (Figure 1). This 
confirms the specificity that each of the ligands has towards G-quadruplex DNAs compared to other 
DNA structures and the strong binding affinity that the ligands have for a G-quadruplex structure. As 
mentioned previously, the ligands are able to cause nanoparticle aggregation, which means that no 
aggregating agent was used. If an aggregating agent was added to the SERS mixture, then it would 
be possible to observe DNA peaks in the spectrum, as well as ligand peaks. Studies have shown that 
SERS can be used to analyse G-quadruplex and duplex sequences without the use of Raman 
reporters, however this was performed using a laser excitation frequency of 785 nm and the 
addition of an aggregating agents such as magnesium sulphate (MgSO4) or spermine.
28, 41
 Here the 
SERS measurements were performed using a laser excitation of 532 nm in the absence of any 
aggregating agent.  
 Figure 5 SERS spectra of each ligand binding to the peroxidase deoxyribozyme quadruplex (black) and the spectra 
obtained when the ligand is in the presence of duplex DNA control sequence (red): (a) spectra of 3AQN binding events; 
(b) spectra of 6AQN binding events and (c) spectra of 360A binding events. All three ligands and G-quadruplex were used 
at 50 µM. The bar chart, (d), is a comparison of the peak intensities of unique peaks of each ligand, highlighted by the 
green circle. In the spectrum of 3AQN, the peak at 1380 cm
-1
 was used for comparison studies, the peak at 719 cm
-1
 in 
the 6AQN spectrum was chosen and for 360A peak intensity studies, the unique peak at 1379 cm
-1
 was used. Spectra 
were obtained using 532 nm laser excitation and an accumulation time of 1 second. All peak intensities were obtained 
by scanning 3 replicate samples 5 times with an accumulation time of 1 second. Averages are shown and error bars are ± 
one standard deviation.  
 
These results were obtained when the ligands and the G-quadruplex DNA in equimolar 
concentrations (50 µM). An investigation was carried out to determine what effect reducing the 
concentration of G-quadruplex, whilst keeping the concentration of ligand constant, would have on 
the SERS response. Figure 6 shows the SERS results obtained when the G-quadruplex concentration 
was reduced from 50 µM to 5 nM. It can be seen that when the G-quadruplex concentration was 
reduced to below 1 µM a SERS response was obtained due to insufficient G-quadruplex being 
present to sequester all of the ligand resulting in signal being obtained. This demonstrates that, as 
expected, the ratio of ligand to G-quadruplex is vital. For example, if the formation of a G-
quadruplex was to be monitored using a lower concentration of DNA then a corresponding lower 
concentration of ligand should be used however, it will be at this point an aggregating agent will be 
required as the amount of ligand present would not cause the aggregation previously obtained. It 
can be clearly seen in Figure 6 that by using the correct ratio of DNA to ligand results in a clear, sharp   
 “ŽŶ to ŽĨĨ ?signal being obtained upon formation of the G-quadruplex.  
  
Figure 6 SERS spectra obtained from G-quadruplex concentration studies using each of the three ligands. The G-
quadruplex concentration was reduced from 50 µM (dark blue), 10 µM (light blue), 5 µM (turquoise), 0.5 µM (green), 
50 nM (yellow), 5 nM (orange) and no G-quadruplex present (red). The concentration of the ligands remained constant 
at 50 µM. (a) SERS spectra of 3AQN obtained when reducing the G-quadruplex concentration. (b) SERS spectra of 6AQN 
obtained when decreasing the G-quadruplex concentration. (c) SERS spectra of 360A obtained when decreasing the G-
quadruplex concentration. (d) Peak intensity comparisons for each of the three ligands using; 1380 cm
-1
 for 3AQN 
comparisons, 719 cm
-1
 for 6AQN comparisons and 1379 cm
-1
 peak intensity comparisons. Spectra were obtained using 
532 nm laser excitation and an accumulation time of 1 second. All peak intensities were obtained by scanning 3 replicate 
samples 5 times with an accumulation time of 1 second. Averages are shown and error bars are ± one standard 
deviation.  
 
Subsequent studies focussed on the ligand 3AQN and its behaviour towards various G-quadruplex 
DNAs and in different salt conditions. Results obtained thus far indicated that in each situation the 
ligand is bound to the G-quadruplex DNAs, i.e. when the ligand ŝƐŶŽůŽŶŐĞƌ “ĨƌĞĞ ? there is a marked 
decrease in SERS intensity. For a G-quadruplex structure to form, it is reported that the presence of a 
monovalent ion, either K
+
 or Na
+
, is essential.
3, 5
 Experiments for this study were originally carried 
out using either 100 mM KCl or 100 mM NaCl to provide these monovalent ions for quadruplex 
formation. However, it was reported that when using certain stabilising agents such as the ligand 
3AQN, neither salt is needed for G-quadruplex formation; the cation presence actually influences the 
orientation of the quadruplex structure, whether it is parallel or antiparallel.
16, 36, 42
 This is due to the 
ability of 3AQN itself, to induce the formation of a G-quadruplex reported by us.
36
 Not only does it 
allow the formation of the desired structure, it also stabilises the quadruplex, which can be exploited 
to detect stable quadruplex structures in vivo.
17
 Figure 7(a-c) shows the SERS spectra obtained when 
NaCl or KCl is present and when salt is replaced by water in the reaction mixture and further analysis 
of the intensity of the peak at 1380 cm 
-1
 was performed (Fig 7d). There was a decrease in the 
absolute SERS intensity when the monovalent ions were absent due to the reduced aggregation of 
the nanoparticles that would have been caused by the salt, however the discrimination between the 
double stranded control DNA sequence and the G-quadruplex DNAs was still very significant.  SERS 
signals were only observed when the G-quadruplex DNA was absent; no SERS signals were observed 
when the ligand was bound to a G-quadruplex sequence, regardless of the salt conditions. This 
further highlights the potential of using 3AQN as a stabilising agent for the formation of G-
quadruplex DNAs as SERS has shown that it stabilises the G-quadruplex in the absence of 
monovalent cations.  
 
Figure 7 SERS spectra of 3AQN complexed to the duplex DNA control sequence in the presence of (a) Na
+
 ions, (b) K
+
 ions 
and (c) no monovalent ions. Spectra were also recorded in the different salt conditions when 3AQN was complexed to 
the peroxidase deoxyribozyme quadruplex sequence. (d) Comparison of peak intensities using the unique peak at 
1380 cm
-1
. Spectra were obtained using 532 nm laser excitation and an accumulation time of 1 second. All peak 
intensities were obtained by scanning 3 replicate samples 5 times with an accumulation time of 1 second. Averages are 
shown and error bars are ± one standard deviation.  
 
G-quadruplex forming sequences are also found in the promoter regions of oncogenes such as C-
MYC. The C-MYC Oncogene is the most common malfunctioning gene in human cancers; therefore it 
is an appealing target for anti-cancer therapies.
43
 The human C-MYC gene is highly regulated and any 
changes in its expression are a crucial point in cancer progression. Detection of these guanine-rich 
sequences is extremely beneficial to the field of cancer diagnostics. Results shown so far have 
proved that 3AQN can be used to successfully determine if a G-quadruplex sequence is present or 
absent. Therefore, studies were carried out to determine if 3AQN would bind to a G-quadruplex 
structure present in telomeric or in a proto-oncogene region such as C-MYC.  
 Figure 8 SERS spectra of 3AQN in the presence of (a) control duplex DNA, (b) human telomeric DNA, (c) C-MYC DNA and 
(d) a comparison of peak intensity at 1380 cm
-1
. Spectra were obtained using 532 nm laser excitation and an 
accumulation time of 1 second. All peak intensities were obtained using the 1380 cm
-1
 peak by scanning 3 replicate 
samples 5 times with an accumulation time of 1 second. Averages are shown and error bars are ± one standard 
deviation.  
 
Figure 8(a-c) shows that ligand peaks are only observed in the absence of a guanine rich DNA 
sequence, regardless of whether it is present in a telomeric end or in a proto-oncogene such as C-
MYC. This demonstrates the strong affinity the ligand 3AQN has for a G-quadruplex topology, 
regardless of where it is found in a biological system and in the absence of the essential monovalent 
ions. Figure 8d is a comparison of the peak intensities at 1380 cm
-1
 and as can clearly be seen there 
is a large discrimination between the ligand in the presence of the duplex control DNA and when the 
ligand is complexed to G-quadruplex DNAs. These results reaffirm the concept of using SERS and a G-
quadruplex binding ligand such as 3AQN as a specific, efficient and reliable qualitative detection 
method of telomeric sequences or cancer promoting genes such as C-MYC. 
 
Conclusions 
Detection of the formation of G-quadruplex DNAs found in the peroxidase deoxyribozyme, telomeric 
region and in the proto-oncogene C-MYC have been demonstrated by a SERS based approach. 
Studies were carried out involving three quadruplex-binding ligands; 360A, 6AQN and 3AQN. Each 
produced successful results allowing detection of the formation of G-quadruplexes with high 
specificity. Further studies were performed using 3AQN that demonstrated the added stabilising 
affect offered by this ligand, due to the fact that the monovalent ions usually required for G-
quadruplex formation are not needed when using 3AQN, can be directly detected using SERS 
without adding additional fluorescent agents and even in a salt-deficient condition. This is due to the 
ability of this ligand itself to both induce the formation of the G-quadruplex structure and give a 
unique SERS response. Since the ligands used here are known to bind/stabilise various quadruplexes, 
this method may be extended to any quadruplex forming sequences present in the biological 
landscape. This study also implies that SERS could be used to distinguish a particular quadruplex 
topology over other quadruplex structures by employing quadruplex-specific ligands. By using SERS, 
reliable results were obtained in a short time frame without the need for extensive laboratory work 
and additional assays. The absence of an aggregating agent resulted in the lack of DNA peaks in the 
SERS spectra, meaning the peaks observed result from the presence of the G-quadruplex stabilising 
ligands. This is a new and information rich approach to higher order DNA structural analysis and 
offers significant opportunities for use in studies involving G-quadruplexes as key biological targets.  
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